GAVIS Launches My Way™ One Step Emergency Contraceptive Pill
SOMERSET, N.J., June 12, 2013 /PRNewswire/ -- GAVIS Pharmaceuticals, LLC announced today that it has launched My Way™, Levonorgestrol 1.5 mg, the generic version of Teva Pharmaceutical's Plan B One Step® emergency contraceptive developed by Novel Laboratories, Inc. My Way™ is available without a prescription to women age 17 years and older.
"GAVIS is committed to bringing quality and affordable drug products to market," Dr. Veerappan Subramanian, CEO of GAVIS, said. "We understand the importance of emergency contraception for women and are proud to offer My Way™, a simple and affordable one pill option."
About My Way™
My Way™ is available over the counter (OTC) at the pharmacy counter to women over the age of 17. My Way™ should be taken within three days (72 hours) of unprotected sex. The sooner it is taken, the better chance it is effective. My Way™ is not effective for women that are already pregnant. My Way™ does not protect against sexually transmitted diseases such as HIV. My Way™ should not be used as a routine birth control, as it is not as effective. If you have severe abdominal pain, you may have an ectopic pregnancy and should get immediate medical help. You are encouraged to report negative side effects of prescription drugs to the FDA at fda.gov/medwatch or call 1-800-FDA-1088.
For more information on My Way™, please visit www.mywaypill.com.
GAVIS Pharmaceuticals, LLC, headquartered in Somerset, New Jersey, markets and distributes a variety of niche generic drug products to customers in the United States through a variety of pharmacies and retailers.
Novel Laboratories, Inc., headquartered in Somerset New Jersey, specializes in research, development and manufacture of generic niche and difficult to develop drug products for the United States, European and Asian markets.
For media inquiries, please contact GAVIS Pharmaceuticals, LLC at 908-603-6000, ext. 1002 or at email@example.com
SOURCE GAVIS Pharmaceuticals, LLC
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.